Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
Cancer Cell
|
December 18, 2014
TRPM3 and miR-204 establish a regulatory circuit that controls oncogenic autophagy in clear cell renal cell carcinoma
Daniel P Hall, Nicholas G Cost, Shailaja Hegde, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 2, 2021
Reuse of Molecules for Glioblastoma Therapy
Abigail Koehler, Aniruddha Karve, Pankaj Desai, et al.
Molecular Cancer Therapeutics
|
September 25, 2025
Preclinical Evaluation of the Efficacy of the Cyclin-Dependent Kinase Inhibitor Ribociclib in Combination with Letrozole against Patient-Derived Glioblastoma Cells
Sidharth N Gadgil, Aniruddha S Karve, Gary A Gudelsky, et al.
Nature Communications
|
October 13, 2015
Transcriptional repression by the HDAC4-RelB-p52 complex regulates multiple myeloma survival and growth
Subrahmanya D Vallabhapurapu, Sunil K Noothi, Derek A Pullum, et al.
International Journal of Cancer
|
June 12, 2013
Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinoma
Dusten Unruh, Kevin Turner, Ramprasad Srinivasan, et al.
Molecular Cancer Therapeutics
|
September 3, 2017
mTOR Kinase Inhibition Effectively Decreases Progression of a Subset of Neuroendocrine Tumors that Progress on Rapalog Therapy and Delays Cardiac Impairment
Melissa A Orr-Asman, Zhengtao Chu, Min Jiang, et al.
Plos One
|
May 16, 2025
CPI203, a BET inhibitor, down-regulates a consistent set of DNA synthesis genes across a wide array of glioblastoma lines
Matthew C Garrett, Troy Carnwath, Rebecca Albano, et al.
Surgical Neurology International
|
June 3, 2026
Predictive capacity of mismatch repair status in the use of immune checkpoint inhibitors for the treatment of aggressive pituitary tumors and pituitary carcinomas: An illustrative case report and literature review
Natalie Ivey, Jeff F Zhang, Abigail Zack, et al.
Scientific Reports
|
August 1, 2023
HDAC1 and HDAC6 are essential for driving growth in IDH1 mutant glioma
Matthew C Garrett, Rebecca Albano, Troy Carnwath, et al.
Cell
|
February 5, 2013
Control of nutrient stress-induced metabolic reprogramming by PKCζ in tumorigenesis
Li Ma, Yongzhen Tao, Angeles Duran, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
Cancer Cell
|
December 18, 2014
TRPM3 and miR-204 establish a regulatory circuit that controls oncogenic autophagy in clear cell renal cell carcinoma
Daniel P Hall, Nicholas G Cost, Shailaja Hegde, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 2, 2021
Reuse of Molecules for Glioblastoma Therapy
Abigail Koehler, Aniruddha Karve, Pankaj Desai, et al.
Molecular Cancer Therapeutics
|
September 25, 2025
Preclinical Evaluation of the Efficacy of the Cyclin-Dependent Kinase Inhibitor Ribociclib in Combination with Letrozole against Patient-Derived Glioblastoma Cells
Sidharth N Gadgil, Aniruddha S Karve, Gary A Gudelsky, et al.
Nature Communications
|
October 13, 2015
Transcriptional repression by the HDAC4-RelB-p52 complex regulates multiple myeloma survival and growth
Subrahmanya D Vallabhapurapu, Sunil K Noothi, Derek A Pullum, et al.
International Journal of Cancer
|
June 12, 2013
Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinoma
Dusten Unruh, Kevin Turner, Ramprasad Srinivasan, et al.
Molecular Cancer Therapeutics
|
September 3, 2017
mTOR Kinase Inhibition Effectively Decreases Progression of a Subset of Neuroendocrine Tumors that Progress on Rapalog Therapy and Delays Cardiac Impairment
Melissa A Orr-Asman, Zhengtao Chu, Min Jiang, et al.
Plos One
|
May 16, 2025
CPI203, a BET inhibitor, down-regulates a consistent set of DNA synthesis genes across a wide array of glioblastoma lines
Matthew C Garrett, Troy Carnwath, Rebecca Albano, et al.
Surgical Neurology International
|
June 3, 2026
Predictive capacity of mismatch repair status in the use of immune checkpoint inhibitors for the treatment of aggressive pituitary tumors and pituitary carcinomas: An illustrative case report and literature review
Natalie Ivey, Jeff F Zhang, Abigail Zack, et al.
Scientific Reports
|
August 1, 2023
HDAC1 and HDAC6 are essential for driving growth in IDH1 mutant glioma
Matthew C Garrett, Rebecca Albano, Troy Carnwath, et al.
Cell
|
February 5, 2013
Control of nutrient stress-induced metabolic reprogramming by PKCζ in tumorigenesis
Li Ma, Yongzhen Tao, Angeles Duran, et al.
Page
of 8